Press Releases
Ferrer initiates second phase III clinical study for Ozenoxacin in adult and paediatric patients with impetigo
Ozenoxacin, a novel bactericidal non-fluorinated quinolone that successfully completed a first phase III clinical trial in adult and paediatric patients with impetigo, is available from...
Press Releases
State-owned British research institute fund Clinical trial of Airsonett – an innovative Swedish asthma treatment
There are 5 million persons suffering from asthma in Great Britain and despite medication, half a million of these persons have symptoms which limit their...
Press Releases
Point of Care Set to Boom in Coming Years; Driving Forward Quality and Maximising Efficiency
The global market for Point of Care diagnostics is set to sharply increase by 2018 and Europe’s market is becoming increasingly competitive due to its...
Press Releases
The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential...
As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and the Early Access to...
Press Releases
Chemistry: Provence Technologies acquires Synprosis
Provence Technologies acquires SynprosisThe acquisition strengthens Provence Technologies’ expertise in its core business of therapeutic chemistryProvence Technologies Group, a specialist fine chemistry research group, today...
Press Releases
Only one week left before BIOVISION, June 5 and 6 Cite Internationale in Lyon, France
Disruptive Innovation – Health – Funding | Immunotherapies – Healthy AgeingOnly one week left to join us in Lyon to meet the key international players...
Press Releases
Orphan Drugs
The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential Revenue Stream in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.